Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginInterest Coverage RatioInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on SalesTimes Interest Earned

Altimmune (ALT) FCF Margin (2016 - 2025)

Altimmune (ALT) has disclosed FCF Margin for 16 consecutive years, with 237940.0% as the latest value for Q3 2025.

  • On a quarterly basis, FCF Margin rose 30442000.0% to 237940.0% in Q3 2025 year-over-year; TTM through Sep 2025 was 331760.0%, a 18153692.0% decrease, with the full-year FY2024 number at 399240.0%, down 38143319.0% from a year prior.
  • FCF Margin was 237940.0% for Q3 2025 at Altimmune, up from 387000.0% in the prior quarter.
  • In the past five years, FCF Margin ranged from a high of 674.95% in Q4 2021 to a low of 755500.0% in Q3 2022.
  • A 5-year average of 217493.35% and a median of 209037.5% in 2022 define the central range for FCF Margin.
  • Peak YoY movement for FCF Margin: tumbled -74420570bps in 2022, then soared 74984061bps in 2023.
  • Altimmune's FCF Margin stood at 674.95% in 2021, then plummeted by -9783bps to 66707.69% in 2022, then skyrocketed by 33bps to 44683.78% in 2023, then crashed by -718bps to 365300.0% in 2024, then soared by 35bps to 237940.0% in 2025.
  • Per Business Quant, the three most recent readings for ALT's FCF Margin are 237940.0% (Q3 2025), 387000.0% (Q2 2025), and 336800.0% (Q1 2025).